MedPath

Effectiveness of SMS (Short Message Service) Text Messaging in Increasing Adherence to Gardasil

Not Applicable
Terminated
Conditions
HPV Vaccines
Interventions
Behavioral: SMS Text Message
Registration Number
NCT01276184
Lead Sponsor
University of Maryland, Baltimore
Brief Summary

Human papillomavirus (HPV) is the most common sexually transmitted disease among adolescent females in the United States. Our primary objective is to determine if Short Message Service (SMS) text message reminders increase adherence to the recommended 3 dose schedule for Gardasil compared to usual care in an outpatient clinic setting. Secondary objectives of this study are: 1) to demonstrate the feasibility of using SMS text message reminders to increase adherence with Gardasil vaccination; and 2) to assess satisfaction and acceptability of text message reminders compared to telephone reminders among women who receive the text message arm of the intervention. The investigators hypothesize that receiving SMS text message reminders will increase adherence to the recommended 3 dose schedule for Gardasil compared to usual care.

Detailed Description

Technological innovations such as Short Message Service (SMS) text messages reminders are one strategy that may be used to increase adherence to the Gardasil dosing schedule. Although the literature in this area is in its infancy, several studies have demonstrated that SMS text reminders are an effective strategy for reducing nonattendance with medical appointments. Further, SMS text message reminders have been shown to be popular with patients and more cost-effective than paper or telephone-based reminder strategies. The investigators believe SMS text message reminders can be used as a feasible and cost-effective strategy to increase adherence to the Gardasil vaccine schedule, thus reducing risk of cervical cancer.

Women who are enrolled will be randomly assigned to one of 2 study groups (Usual Care v. SMS Text Message group). For women in the SMS Text Message group, text message reminders will be sent once per day for each of the seven days prior to the scheduled date for each of their follow up vaccinations. Participants follow the usual practices for scheduling their follow up visit(s) for vaccination at the clinic. Participants in both the Usual Care group and the SMS Text Message group will receive the standard reminder from the clinic for their scheduled appointment(s) (phone call, letter, etc, as appropriate). At enrollment, the participant will answer questions regarding social and demographic history, cell phone use patterns, attitudes and acceptance of HPV vaccine, gynecologic and sexual history.

All participants will be sent a packet of self-report measures to complete regarding attitudes toward HPV vaccination at the completion of the study. Participants in the SMS Text Message group will also receive rating scales to assess acceptability of text message reminders and preference for text message reminders over telephone reminders.

Recruitment & Eligibility

Status
TERMINATED
Sex
Female
Target Recruitment
22
Inclusion Criteria
  • Have a mobile phone with text message capability
  • Patient of University of Maryland Medical Center outpatient gynecology clinics
  • Able to speak and read English
  • Capable of understanding, consenting, and complying with the entire study protocol
Exclusion Criteria
  • Pregnant
  • Previously completed the Gardasil vaccine

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
SMS Text MessageSMS Text MessageParticipants in both the Usual Care group and the SMS Text Message group will receive the standard reminder from the clinic for their scheduled appointment(s) (phone call, letter, etc, as appropriate). Women in the SMS Text Message group that reschedule a vaccination visit will receive text message reminders one per day for each of the seven days prior to the rescheduled visit.
Primary Outcome Measures
NameTimeMethod
Number of Participants That Adhered to Vaccine Scheduleat the end of the study (30 days after the third vaccination or 360 days after the first vaccination, whichever comes first)

Our primary objective is to determine if Short Message Service (SMS) text message reminders increase number of participants that adhered to the recommended 3 dose schedule for Gardasil compared to usual care in an outpatient clinic setting.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Western-Penn Center

🇺🇸

Baltimore, Maryland, United States

Redwood Clinic

🇺🇸

Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath